Hong Kong Stock Exchange · Healthcare
Invest in 160 Health International stock from India
Indian and foreign residents can buy 160 Health International (2656) shares directly through Paasa.
By Paasa · Updated
160 Health International at a glance
- Price
- HK$3.49-HK$0.24 (6.43%)
- Market cap
- HK$1.21B
- Day range
- HK$3.48 – HK$3.81
- P/E
- —
- Dividend yield
- None
- Volume
- 13.13M
- 1 month
- -66.15%
- 6 months
- -96.44%
- YTD
- -93.69%
- 1 year
- -88.44%
- 5 years
- —
How to invest in 160 Health International from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to HKD when you buy.
Step 3
Search 2656 and buy
Find 160 Health International by name or by its ticker, 2656, and place your order. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
Why invest in 160 Health International from India
What 160 Health International does
160 Health International Limited wholesales and retails pharmaceutical and healthcare products in China. Thedevelops Healthcare 160 Platform, an online healthcare and wellness service platform which provides digital healthcare and wellness solutions, including online marketing solutions, digital hospital solutions, and online healthcare services to business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants. 160 Health International Limited was founded in 2005 and is headquartered in Shenzhen, the People's Republic of China. 160 Health International operates in the Medical - Distribution industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy 160 Health International stock from India?
Yes. Indian residents and NRIs can buy 160 Health International (2656) shares directly through Paasa. 160 Health International is listed on the Hong Kong Stock Exchange, in the Medical - Distribution industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
Do I need to buy a full 160 Health International share?
Usually more than one, and not a fraction: many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. At HK$3.49 a share, size the order by the lot, not by the share.
How are 160 Health International dividends taxed for Indian investors?
160 Health International trades on the Hong Kong Stock Exchange but is domiciled in China, so any withholding on its dividends follows that country's rules rather than those of Hong Kong. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.
What tax do I pay in India when I sell 160 Health International shares?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the HKD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.